| Roxanne Nason, | |
|
897 W Main St, Dover Foxcroft, ME 04426-1029 | |
| (207) 564-4338 | |
| Not Available |
| Full Name | Roxanne Nason |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Occupational Health |
| Location | 897 W Main St, Dover Foxcroft, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598150625 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WX0106X | Registered Nurse - Occupational Health | RN19727 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Roxanne Nason, 897 W Main St, Dover Foxcroft, ME 04426-1029 Ph: () - | Roxanne Nason, 897 W Main St, Dover Foxcroft, ME 04426-1029 Ph: (207) 564-4338 |
News Archive
The American Academy of Audiology on behalf of audiologists, and the Hearing Loss Association of America on behalf of people with hearing loss announce a collaborative public education campaign "Get in the Hearing Loop."
Until now, patients with heart failure with preserved ejection fraction – the most common type of heart failure in the elderly – have had no access to evidenced-based treatments. For the first time, a large clinical trial led by Prof. Dr. Stefan Anker from Charité – Universitätsmedizin Berlin has identified a drug which has a distinctly positive effect on prognosis. In patients affected by this type of heart failure, the drug – empagliflozin – reduces the risk of hospitalization or cardiovascular death by 21 percent. The results of this research have been published in the New England Journal of Medicine.
Researchers say a new development in cord blood transplants for inherited metabolic disorders may be curative for some babies who are treated while still in the womb.
Elusys Therapeutics, Inc., a biopharmaceutical company developing biodefense countermeasures, announced today that it has been awarded the first U.S. Government contract to develop an anti-toxin for pre- and post-exposure prophylaxis (PEP) use via intramuscular injection.
› Verified 8 days ago
Cheri K Schriver, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 48 E Main St, Dover Foxcroft, ME 04426 Phone: 207-538-3700 Fax: 207-528-2595 | |
Mrs. Sally L. Larrabee, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 572 Bangor Rd, Dover Foxcroft, ME 04426 Phone: 207-564-2464 Fax: 207-564-2404 | |
Sandra Engstrom, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 43 Dwelley Ave, Dover Foxcroft, ME 04426 Phone: 207-564-4143 | |
Jody Annis, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 891 W Main St, Suite 200, Dover Foxcroft, ME 04426 Phone: 207-564-4157 | |
Teresa M Jay, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 188 Summer St, Dover Foxcroft, ME 04426 Phone: 207-523-3700 Fax: 207-528-2880 | |
Melissa Ware, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 897 W Main St, Dover Foxcroft, ME 04426 Phone: 207-564-4262 |